Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
MARKETS
S&P 500 Closes at Record; Stocks Extend Win Streak to Four
By Joseph Woelfel
20 hours ago
INVESTING
Bristol-Myers Flat After Report - Here's the Must-Hold Support Level
By Bret Kenwell
23 hours ago
INVESTING
When to Buy Merck as Shares Fall After Earnings
By Bret Kenwell
Feb 4, 2021 11:29 AM EST
INVESTING
Merck, Bristol Myers Squibb, PayPal, Apple - Thursday's Premarket Movers
By Vidhi Choudhary
Feb 4, 2021 8:33 AM EST
INVESTING
Merck Misses Q4 Earnings Forecast; CEO Ken Frazier to Retire
By Martin Baccardax
Feb 4, 2021 9:37 AM EST
PRESS RELEASES
Kenneth C. Frazier To Retire As Merck CEO; Board Elects Robert M. Davis As Successor; Frazier To Continue As Executive Chairman
By Business Wire
Feb 4, 2021 6:40 AM EST
MARKETS
Stimulus Checks, PayPal, Dogecoin, Merck, Ford - 5 Things You Must Know Thursday
By Joseph Woelfel
Feb 4, 2021 8:31 AM EST
MARKETS
Stocks End Higher as Retail Trading Frenzy Ebbs, Nasdaq Jumps 2.6%
By Joseph Woelfel
Feb 1, 2021 4:21 PM EST
PRESS RELEASES
Dr. Stephen Mayo Elected To Merck Board Of Directors
By Business Wire
Feb 1, 2021 6:45 AM EST
INVESTING
Dow Futures Rebound, Silver Surges To Seven-Year High As Reddit Retail Army Targets Metals
By Martin Baccardax
Feb 1, 2021 9:10 AM EST
MARKETS
Silver, GameStop, Robinhood, Amazon, Exxon and Chevron - 5 Things You Must Know Monday
By Joseph Woelfel
Feb 1, 2021 8:06 AM EST
PRESS RELEASES
Merck Presents Results From Head-to-Head Phase 3 KEYNOTE-598 Trial Evaluating KEYTRUDA® (pembrolizumab) In Combination With Ipilimumab Versus KEYTRUDA Monotherapy In Certain Patients With Metastatic Non-Small Cell Lung Cancer
By Business Wire
Jan 29, 2021 7:23 PM EST
PRESS RELEASES
Merck Announces Second Cohort Of Safer Childbirth Cities Organizations Committed To Improving Maternal Health Equity And Reducing Preventable Maternal Deaths In The US
By Business Wire
Jan 27, 2021 8:00 AM EST
PRESS RELEASES
Merck Announces Second-Quarter 2021 Dividend
By Business Wire
Jan 26, 2021 1:15 PM EST
PRESS RELEASES
Merck Presents Interim Findings From Phase 2a Clinical Trial Evaluating Investigational Once-Monthly Oral Islatravir For The Prevention Of HIV-1 Infection At HIVR4P 2021
By Business Wire
Jan 26, 2021 9:06 AM EST
INVESTING
Buy-the-Dip Candidates in the Stock Market: Aurora Cannabis Falls
By Danny Peterson
Jan 25, 2021 9:46 AM EST
INVESTING
GameStop, Tesla, Apple, AMC - Monday's Premarket Movers
By Vidhi Choudhary
Jan 25, 2021 8:12 AM EST
INVESTING
Merck Dumps COVID Vaccine Program After Poor Immune Response in Early Trials
By Martin Baccardax
Jan 25, 2021 9:40 AM EST
PRESS RELEASES
Merck Discontinues Development Of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development Of Two Investigational Therapeutic Candidates
By Business Wire
Jan 25, 2021 6:45 AM EST
PRESS RELEASES
Merck Announces U.S. FDA Approval Of VERQUVO® (vericiguat)
By Business Wire
Jan 20, 2021 6:45 AM EST
INVESTING
Gilead Up on Patent-Dispute Win and Morgan Stanley Upgrade
By Dan Weil
Jan 19, 2021 1:35 PM EST
PRESS RELEASES
U.S. FDA Accepts For Priority Review The Biologics License Application For V114, Merck's Investigational 15-valent Pneumococcal Conjugate Vaccine, For Use In Adults 18 Years Of Age And Older
By Business Wire
Jan 12, 2021 6:45 AM EST
PRESS RELEASES
Merck To Hold Fourth-Quarter And Full-Year 2020 Sales And Earnings Conference Call On February 4
By Business Wire
Jan 8, 2021 6:45 AM EST
INVESTING
5 Worst Stocks in the Dow on Wednesday: Intel Slips
By Vidhi Choudhary
Dec 30, 2020 5:52 PM EST
INVESTING
Best Healthcare Stocks to Buy in 2021
By Stephen Guilfoyle
Jan 30, 2021 11:35 AM EST